Why the study?
Do drug-eluting stents reduce target vessel revascularization and mortality in diabetic patients undergoing PCI compared to bare metal stents?
Do drug-eluting stents reduce target vessel revascularization and mortality in diabetic patients undergoing PCI compared to bare metal stents?
In diabetic patients undergoing PCI, the use of drug-eluting stents significantly reduces the risk of target vessel revascularization compared to bare metal stents, with a non-significant trend toward improved survival.
Answers are grounded in this paper and cite their sources.
DES may lower TVR in diabetic PCI patients; hypothesis-generating for survival benefit and requires RCT confirmation.
OBJECTIVES: We sought to determine if differences existed in in-hospital outcomes, long-term rates of target vessel revascularization (TVR), and/or long-term mortality trends between patients with diabetes mellitus undergoing percutaneous coronary intervention (PCI) with either a drug-eluting stent(s) (DES) or a bare metal stent(s) (BMS). BACKGROUND: Short- and long-term clinical outcomes of patients with diabetes mellitus undergoing PCI with DES versus BMS remain inconsistent between randomized-controlled trials (RCTs) and observational studies. METHODS: Data were collected prospectively on diabetics undergoing PCI with either DES or BMS from January 2000 to June 2008. Demographic information, medical histories, in-hospital outcomes, and long-term TVR and mortality trends were obtained for all patients. RESULTS: A total of 1,319 patients were included in the study. Diabetics receiving DES had a significant reduction in index admission MACE compared to diabetics receiving BMS. Using multivariable adjustment, after a mean follow-up of 2.5 years (maximum 5 years), diabetics who received DES had a 38% decreased risk of TVR compared to diabetics with BMS [HR 0.62 (95% CI: 0.43-0.90)]; diabetics with DES had an insignificant adjusted improvement in long-term survival compared to diabetics with BMS [HR 0.72 (95% CI: 0.52-1.00)]. These long-term survival and TVR rates were confirmed using propensity scoring. CONCLUSIONS: The use of DES when compared with BMS among diabetics undergoing PCI is associated with significant improvement in long-term TVR, with an insignificant similar trend in all-cause mortality. The long-term results of this observational study are consistent with prior RCTs after adjusting for confounding variables.
No takes yet. Share an insight, caveat, or question.
Ramanath et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: